Balsalazide
RxNorm 18747
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 18747 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: balsalazide.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Balsalazide
(Atom ID: 388862)
PTPrescribable
Designated preferred name (PT):
Balsalazide
(Atom ID: 2545023)
FNPrescribable
Full form of descriptor (FN):
Balsalazide (substance)
(Atom ID: 2545025)
PTPrescribable
Designated preferred name (PT):
Balsalazide-containing product
(Atom ID: 10797464)
FNPrescribable
Full form of descriptor (FN):
Product containing balsalazide (medicinal product)
(Atom ID: 9254133)
Patient Education
Balsalazide
Balsalazide is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum). Balsalazide is an anti-inflammatory drug. It is converted in the body to mesalamine and works by reducing bowel inflammation, diarrhea, rectal bleeding, and stomach pain. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.